Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Heterogeneous local dynamics revealed by classification analysis of spatially disaggregated time series data.

Perkins TA, Rodriguez-Barraquer I, Manore C, Siraj AS, España G, Barker CM, Johansson MA, Reiner RC Jr.

Epidemics. 2019 Dec;29:100357. doi: 10.1016/j.epidem.2019.100357. Epub 2019 Jul 22.

2.

The impact of multiple rounds of indoor residual spraying on malaria incidence and haemoglobin levels in a high transmission setting.

Zinszer K, Charland K, Vahey S, Jahagirdar D, Rek JC, Arinaitwe E, Nankabirwa J, Morrison K, Sadoine ML, Tutt-Guérette MA, Staedke SG, Kamya MR, Greenhouse B, Rodriguez-Barraquer I, Dorsey G.

J Infect Dis. 2019 Oct 10. pii: jiz453. doi: 10.1093/infdis/jiz453. [Epub ahead of print]

PMID:
31599325
3.

Heterogeneous exposure and hotspots for malaria vectors at three study sites in Uganda.

Kang SY, Battle KE, Gibson HS, Cooper LV, Maxwell K, Kamya M, Lindsay SW, Dorsey G, Greenhouse B, Rodriguez-Barraquer I, Reiner RCJ, Smith DL, Bisanzio D.

Version 2. Gates Open Res. 2018 Nov 13 [revised 2018 Jan 1];2:32. doi: 10.12688/gatesopenres.12838.2. eCollection 2018.

4.

Pareto rules for malaria super-spreaders and super-spreading.

Cooper L, Kang SY, Bisanzio D, Maxwell K, Rodriguez-Barraquer I, Greenhouse B, Drakeley C, Arinaitwe E, G Staedke S, Gething PW, Eckhoff P, Reiner RC Jr, Hay SI, Dorsey G, Kamya MR, Lindsay SW, Grenfell BT, Smith DL.

Nat Commun. 2019 Sep 2;10(1):3939. doi: 10.1038/s41467-019-11861-y.

5.

Serological inference of past primary and secondary dengue infection: implications for vaccination.

Lam HM, Phuong HT, Thao Vy NH, Le Thanh NT, Dung PN, Ngoc Muon TT, Van Vinh Chau N, Rodríguez-Barraquer I, Cummings DAT, Wills BA, Boni MF, Rabaa MA, Clapham HE.

J R Soc Interface. 2019 Jul 26;16(156):20190207. doi: 10.1098/rsif.2019.0207. Epub 2019 Jul 31.

6.

Opportunities for improved surveillance and control of dengue from age-specific case data.

Rodriguez-Barraquer I, Salje H, Cummings DA.

Elife. 2019 May 23;8. pii: e45474. doi: 10.7554/eLife.45474.

7.

Nationally-representative serostudy of dengue in Bangladesh allows generalizable disease burden estimates.

Salje H, Paul KK, Paul R, Rodriguez-Barraquer I, Rahman Z, Alam MS, Rahman M, Al-Amin HM, Heffelfinger J, Gurley E.

Elife. 2019 Apr 8;8. pii: e42869. doi: 10.7554/eLife.42869.

8.

Impact of Microscopic and Submicroscopic Parasitemia During Pregnancy on Placental Malaria in a High-Transmission Setting in Uganda.

Briggs J, Ategeka J, Kajubi R, Ochieng T, Kakuru A, Ssemanda C, Wasswa R, Jagannathan P, Greenhouse B, Rodriguez-Barraquer I, Kamya M, Dorsey G.

J Infect Dis. 2019 Jul 2;220(3):457-466. doi: 10.1093/infdis/jiz130.

PMID:
30891605
9.

Long-term circulation of Zika virus in Thailand: an observational study.

Ruchusatsawat K, Wongjaroen P, Posanacharoen A, Rodriguez-Barraquer I, Sangkitporn S, Cummings DAT, Salje H.

Lancet Infect Dis. 2019 Apr;19(4):439-446. doi: 10.1016/S1473-3099(18)30718-7. Epub 2019 Feb 27. Erratum in: Lancet Infect Dis. 2019 Mar 8;:.

PMID:
30826189
10.

Impact of preexisting dengue immunity on Zika virus emergence in a dengue endemic region.

Rodriguez-Barraquer I, Costa F, Nascimento EJM, Nery N Júnior, Castanha PMS, Sacramento GA, Cruz J, Carvalho M, De Olivera D, Hagan JE, Adhikarla H, Wunder EA Jr, Coêlho DF, Azar SR, Rossi SL, Vasilakis N, Weaver SC, Ribeiro GS, Balmaseda A, Harris E, Nogueira ML, Reis MG, Marques ETA, Cummings DAT, Ko AI.

Science. 2019 Feb 8;363(6427):607-610. doi: 10.1126/science.aav6618.

PMID:
30733412
11.

Dengue pre-vaccination screening and positive predictive values.

Rodríguez-Barraquer I, Salje H, Cummings DA.

Lancet Infect Dis. 2019 Feb;19(2):132-134. doi: 10.1016/S1473-3099(18)30799-0. Epub 2019 Jan 30. No abstract available.

PMID:
30712834
12.

Persistent Parasitemia Despite Dramatic Reduction in Malaria Incidence After 3 Rounds of Indoor Residual Spraying in Tororo, Uganda.

Nankabirwa JI, Briggs J, Rek J, Arinaitwe E, Nayebare P, Katrak S, Staedke SG, Rosenthal PJ, Rodriguez-Barraquer I, Kamya MR, Dorsey G, Greenhouse B.

J Infect Dis. 2019 Mar 15;219(7):1104-1111. doi: 10.1093/infdis/jiy628.

PMID:
30383230
13.

Viridot: An automated virus plaque (immunofocus) counter for the measurement of serological neutralizing responses with application to dengue virus.

Katzelnick LC, Coello Escoto A, McElvany BD, Chávez C, Salje H, Luo W, Rodriguez-Barraquer I, Jarman R, Durbin AP, Diehl SA, Smith DJ, Whitehead SS, Cummings DAT.

PLoS Negl Trop Dis. 2018 Oct 24;12(10):e0006862. doi: 10.1371/journal.pntd.0006862. eCollection 2018 Oct.

14.

Taking Sharper Pictures of Malaria with CAMERAs: Combined Antibodies to Measure Exposure Recency Assays.

Greenhouse B, Smith DL, Rodríguez-Barraquer I, Mueller I, Drakeley CJ.

Am J Trop Med Hyg. 2018 Nov;99(5):1120-1127. doi: 10.4269/ajtmh.18-0303. Review.

15.

Dynamics and determinants of the force of infection of dengue virus from 1994 to 2015 in Managua, Nicaragua.

Katzelnick LC, Ben-Shachar R, Mercado JC, Rodriguez-Barraquer I, Elizondo D, Arguello S, Nuñez A, Ojeda S, Sanchez N, Lopez Mercado B, Gresh L, Burger-Calderon R, Kuan G, Gordon A, Balmaseda A, Harris E.

Proc Natl Acad Sci U S A. 2018 Oct 16;115(42):10762-10767. doi: 10.1073/pnas.1809253115. Epub 2018 Sep 28.

16.

Quantification of anti-parasite and anti-disease immunity to malaria as a function of age and exposure.

Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, Kamya MR, Rosenthal PJ, Rek J, Dorsey G, Nankabirwa J, Staedke SG, Kilama M, Drakeley C, Ssewanyana I, Smith DL, Greenhouse B.

Elife. 2018 Jul 25;7. pii: e35832. doi: 10.7554/eLife.35832.

17.

Dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria during pregnancy and risk of malaria in early childhood: A randomized controlled trial.

Jagannathan P, Kakuru A, Okiring J, Muhindo MK, Natureeba P, Nakalembe M, Opira B, Olwoch P, Nankya F, Ssewanyana I, Tetteh K, Drakeley C, Beeson J, Reiling L, Clark TD, Rodriguez-Barraquer I, Greenhouse B, Wallender E, Aweeka F, Prahl M, Charlebois ED, Feeney ME, Havlir DV, Kamya MR, Dorsey G.

PLoS Med. 2018 Jul 17;15(7):e1002606. doi: 10.1371/journal.pmed.1002606. eCollection 2018 Jul.

18.

Reconstruction of antibody dynamics and infection histories to evaluate dengue risk.

Salje H, Cummings DAT, Rodriguez-Barraquer I, Katzelnick LC, Lessler J, Klungthong C, Thaisomboonsuk B, Nisalak A, Weg A, Ellison D, Macareo L, Yoon IK, Jarman R, Thomas S, Rothman AL, Endy T, Cauchemez S.

Nature. 2018 May;557(7707):719-723. doi: 10.1038/s41586-018-0157-4. Epub 2018 May 23.

19.

Spatiotemporal incidence of Zika and associated environmental drivers for the 2015-2016 epidemic in Colombia.

Siraj AS, Rodriguez-Barraquer I, Barker CM, Tejedor-Garavito N, Harding D, Lorton C, Lukacevic D, Oates G, Espana G, Kraemer MUG, Manore C, Johansson MA, Tatem AJ, Reiner RC, Perkins TA.

Sci Data. 2018 Apr 24;5:180073. doi: 10.1038/sdata.2018.73.

20.

High Hepatitis E Seroprevalence Among Displaced Persons in South Sudan.

Azman AS, Bouhenia M, Iyer AS, Rumunu J, Laku RL, Wamala JF, Rodriguez-Barraquer I, Lessler J, Gignoux E, Luquero FJ, Leung DT, Gurley ES, Ciglenecki I.

Am J Trop Med Hyg. 2017 Jun;96(6):1296-1301. doi: 10.4269/ajtmh.16-0620.

21.

Impact of interventions and the incidence of ebola virus disease in Liberia-implications for future epidemics.

Kirsch TD, Moseson H, Massaquoi M, Nyenswah TG, Goodermote R, Rodriguez-Barraquer I, Lessler J, Cumings DA, Peters DH.

Health Policy Plan. 2017 Mar 1;32(2):205-214. doi: 10.1093/heapol/czw113. Erratum in: Health Policy Plan. 2017 May 1;32(4):602.

22.

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study.

Flasche S, Jit M, Rodríguez-Barraquer I, Coudeville L, Recker M, Koelle K, Milne G, Hladish TJ, Perkins TA, Cummings DA, Dorigatti I, Laydon DJ, España G, Kelso J, Longini I, Lourenco J, Pearson CA, Reiner RC, Mier-Y-Terán-Romero L, Vannice K, Ferguson N.

PLoS Med. 2016 Nov 29;13(11):e1002181. doi: 10.1371/journal.pmed.1002181. eCollection 2016 Nov.

23.

Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment.

Ferguson NM, Rodríguez-Barraquer I, Dorigatti I, Mier-Y-Teran-Romero L, Laydon DJ, Cummings DA.

Science. 2016 Sep 2;353(6303):1033-1036.

24.

Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children.

Rodriguez-Barraquer I, Arinaitwe E, Jagannathan P, Boyle MJ, Tappero J, Muhindo M, Kamya MR, Dorsey G, Drakeley C, Ssewanyana I, Smith DL, Greenhouse B.

J Infect Dis. 2016 Oct 1;214(7):1072-80. doi: 10.1093/infdis/jiw301. Epub 2016 Aug 1.

25.

Assessing the global threat from Zika virus.

Lessler J, Chaisson LH, Kucirka LM, Bi Q, Grantz K, Salje H, Carcelen AC, Ott CT, Sheffield JS, Ferguson NM, Cummings DA, Metcalf CJ, Rodriguez-Barraquer I.

Science. 2016 Aug 12;353(6300):aaf8160. doi: 10.1126/science.aaf8160. Epub 2016 Jul 14. Review.

26.

Dependability of results in conference abstracts of randomized controlled trials in ophthalmology and author financial conflicts of interest as a factor associated with full publication.

Saldanha IJ, Scherer RW, Rodriguez-Barraquer I, Jampel HD, Dickersin K.

Trials. 2016 Apr 26;17(1):213. doi: 10.1186/s13063-016-1343-z.

27.

Dengue Vaccine in Regions of Endemic Disease.

Rodriguez-Barraquer I, Salje H, Cummings DA.

N Engl J Med. 2016 Apr 7;374(14):1388. doi: 10.1056/NEJMc1514451. No abstract available.

PMID:
27050220
28.

Dengue Virus (DENV) Neutralizing Antibody Kinetics in Children After Symptomatic Primary and Postprimary DENV Infection.

Clapham HE, Rodriguez-Barraquer I, Azman AS, Althouse BM, Salje H, Gibbons RV, Rothman AL, Jarman RG, Nisalak A, Thaisomboonsuk B, Kalayanarooj S, Nimmannitya S, Vaughn DW, Green S, Yoon IK, Cummings DA.

J Infect Dis. 2016 May 1;213(9):1428-35. doi: 10.1093/infdis/jiv759. Epub 2015 Dec 23.

29.

Reconstruction of 60 Years of Chikungunya Epidemiology in the Philippines Demonstrates Episodic and Focal Transmission.

Salje H, Cauchemez S, Alera MT, Rodriguez-Barraquer I, Thaisomboonsuk B, Srikiatkhachorn A, Lago CB, Villa D, Klungthong C, Tac-An IA, Fernandez S, Velasco JM, Roque VG Jr, Nisalak A, Macareo LR, Levy JW, Cummings D, Yoon IK.

J Infect Dis. 2016 Feb 15;213(4):604-10. doi: 10.1093/infdis/jiv470. Epub 2015 Sep 25.

30.

The Hidden Burden of Dengue and Chikungunya in Chennai, India.

Rodríguez-Barraquer I, Solomon SS, Kuganantham P, Srikrishnan AK, Vasudevan CK, Iqbal SH, Balakrishnan P, Solomon S, Mehta SH, Cummings DA.

PLoS Negl Trop Dis. 2015 Jul 16;9(7):e0003906. doi: 10.1371/journal.pntd.0003906. eCollection 2015.

31.

Differential efficacy of dengue vaccine by immune status.

Rodriguez-Barraquer I, Mier-Y-Teran-Romero L, Ferguson N, Burke DS, Cummings DAT.

Lancet. 2015 May 2;385(9979):1726. doi: 10.1016/S0140-6736(15)60889-3. No abstract available.

PMID:
25943936
32.

Robust, reproducible, industrialized, standard membrane feeding assay for assessing the transmission blocking activity of vaccines and drugs against Plasmodium falciparum.

Li T, Eappen AG, Richman AM, Billingsley PF, Abebe Y, Li M, Padilla D, Rodriguez-Barraquer I, Sim BK, Hoffman SL.

Malar J. 2015 Apr 9;14:150. doi: 10.1186/s12936-015-0665-8.

33.

Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014.

Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, Truelove S, Hakeem R, Albarrak A, Ferguson NM; MERS-CoV Scenario Modeling Working Group; MERS-CoV Scenario Modeling Working Group.

PLoS Curr. 2014 Nov 24;6. pii: ecurrents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369. doi: 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369.

34.

Enhancing disease surveillance with novel data streams: challenges and opportunities.

Althouse BM, Scarpino SV, Meyers LA, Ayers JW, Bargsten M, Baumbach J, Brownstein JS, Castro L, Clapham H, Cummings DA, Del Valle S, Eubank S, Fairchild G, Finelli L, Generous N, George D, Harper DR, Hébert-Dufresne L, Johansson MA, Konty K, Lipsitch M, Milinovich G, Miller JD, Nsoesie EO, Olson DR, Paul M, Polgreen PM, Priedhorsky R, Read JM, Rodríguez-Barraquer I, Smith DJ, Stefansen C, Swerdlow DL, Thompson D, Vespignani A, Wesolowski A.

EPJ Data Sci. 2015;4. pii: 17. doi: 10.1140/epjds/s13688-015-0054-0. Epub 2015 Oct 16.

35.

Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development.

Salje H, Rodríguez-Barraquer I, Rainwater-Lovett K, Nisalak A, Thaisomboonsuk B, Thomas SJ, Fernandez S, Jarman RG, Yoon IK, Cummings DA.

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2952. doi: 10.1371/journal.pntd.0002952. eCollection 2014 Jun.

36.

Potential opportunities and perils of imperfect dengue vaccines.

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Schwartz IB, Burke DS, Cummings DA.

Vaccine. 2014 Jan 16;32(4):514-20. doi: 10.1016/j.vaccine.2013.11.020. Epub 2013 Nov 19.

37.

Revisiting Rayong: shifting seroprofiles of dengue in Thailand and their implications for transmission and control.

Rodríguez-Barraquer I, Buathong R, Iamsirithaworn S, Nisalak A, Lessler J, Jarman RG, Gibbons RV, Cummings DA.

Am J Epidemiol. 2014 Feb 1;179(3):353-60. doi: 10.1093/aje/kwt256. Epub 2013 Nov 5.

38.

Challenges in the interpretation of dengue vaccine trial results.

Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Burke DS, Cummings DA.

PLoS Negl Trop Dis. 2013 Aug 29;7(8):e2126. doi: 10.1371/journal.pntd.0002126. eCollection 2013. No abstract available.

39.

Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis.

Rainwater-Lovett K, Rodriguez-Barraquer I, Cummings DA, Lessler J.

BMC Infect Dis. 2012 Sep 28;12:233. doi: 10.1186/1471-2334-12-233. Review.

40.

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.

Rubiano LC, Miranda MC, Muvdi Arenas S, Montero LM, Rodríguez-Barraquer I, Garcerant D, Prager M, Osorio L, Rojas MX, Pérez M, Nicholls RS, Gore Saravia N.

J Infect Dis. 2012 Feb 15;205(4):684-92. doi: 10.1093/infdis/jir816. Epub 2012 Jan 11.

41.

From re-emergence to hyperendemicity: the natural history of the dengue epidemic in Brazil.

Rodriguez-Barraquer I, Cordeiro MT, Braga C, de Souza WV, Marques ET, Cummings DA.

PLoS Negl Trop Dis. 2011 Jan 4;5(1):e935. doi: 10.1371/journal.pntd.0000935.

42.

Etiologic agent of an epidemic of cutaneous leishmaniasis in Tolima, Colombia.

Rodríguez-Barraquer I, Góngora R, Prager M, Pacheco R, Montero LM, Navas A, Ferro C, Miranda MC, Saravia NG.

Am J Trop Med Hyg. 2008 Feb;78(2):276-82.

PMID:
18256429

Supplemental Content

Loading ...
Support Center